Literature DB >> 22328144

Endogenous mechanisms underlying the activation and sensitization of meningeal nociceptors: the role of immuno-vascular interactions and cortical spreading depression.

Dan Levy1.   

Abstract

Migraine is considered one of the most prevalent neurological disorders but its underlying pathophysiology is poorly understood. Over the past two decades, it became widely accepted that activation of primary afferent nociceptive neurons that innervate the intracranial meninges serves as a key process that mediates the throbbing head pain of migraine. Knowledge about the endogenous factors that play a role in promoting this neural process during a migraine attack slowly begins to increase, and a better understanding remains one of the holy grails in migraine research. One endogenous process, which has been invoked as a major player in the genesis of migraine pain, is cortical spreading depression (CSD). Until recently, however, this notion was only supported by indirect evidence. Recently, electrophysiological data provided the first direct evidence that CSD is indeed a powerful endogenous process that can lead to persistent activation of meningeal nociceptors and the migraine pain pathway. CSD has been suggested to promote persistent sensitization and ensuing activation of meningeal nociceptors through a mechanism involving local neurogenic inflammation including the activation of mast cells and macrophages and subsequent release of inflammatory mediators. Local action of such nociceptive mediators can increase the responsiveness of meningeal nociceptors. Recent studies provided key experimental data implicating complex meningeal immuno-vascular interactions, in particular, the interplay between proinflammatory cytokines, the meningeal vasculature and immune cells, in enhancing the responses of meningeal nociceptors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22328144     DOI: 10.1007/s11916-012-0255-1

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  85 in total

Review 1.  Clinical relevance of cortical spreading depression in neurological disorders: migraine, malignant stroke, subarachnoid and intracranial hemorrhage, and traumatic brain injury.

Authors:  Martin Lauritzen; Jens Peter Dreier; Martin Fabricius; Jed A Hartings; Rudolf Graf; Anthony John Strong
Journal:  J Cereb Blood Flow Metab       Date:  2010-11-03       Impact factor: 6.200

2.  Spreading depression: from serendipity to targeted therapy in migraine prophylaxis.

Authors:  C Ayata
Journal:  Cephalalgia       Date:  2009-10       Impact factor: 6.292

3.  Cerebral glucose utilization: local changes during and after recovery from spreading cortical depression.

Authors:  M Shinohara; B Dollinger; G Brown; S Rapoport; L Sokoloff
Journal:  Science       Date:  1979-01-12       Impact factor: 47.728

4.  Sumatriptan for high-altitude headache.

Authors:  P Bärtsch; S Maggi; G R Kleger; P E Ballmer; R W Baumgartner
Journal:  Lancet       Date:  1994-11-19       Impact factor: 79.321

Review 5.  Migraine pain, meningeal inflammation, and mast cells.

Authors:  Dan Levy
Journal:  Curr Pain Headache Rep       Date:  2009-06

Review 6.  Neurokinin 1 receptor antagonists--current prospects.

Authors:  Giuseppe Alvaro; Romano Di Fabio
Journal:  Curr Opin Drug Discov Devel       Date:  2007-09

7.  Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine.

Authors:  J Olesen; B Larsen; M Lauritzen
Journal:  Ann Neurol       Date:  1981-04       Impact factor: 10.422

8.  Expression of c-fos-like immunoreactivity in brainstem after meningeal irritation by blood in the subarachnoid space.

Authors:  K Nozaki; P Boccalini; M A Moskowitz
Journal:  Neuroscience       Date:  1992-08       Impact factor: 3.590

9.  A preliminary report on hyperbaric oxygen in the relief of migraine headache.

Authors:  D E Myers; R A Myers
Journal:  Headache       Date:  1995-04       Impact factor: 5.887

10.  TNFalpha mechanically sensitizes masseter muscle afferent fibers of male rats.

Authors:  Akhlaq W Hakim; Xu-Dong Dong; Peter Svensson; Ujendra Kumar; Brian E Cairns
Journal:  J Neurophysiol       Date:  2009-06-24       Impact factor: 2.714

View more
  46 in total

1.  Dissociation between CSD-Evoked Metabolic Perturbations and Meningeal Afferent Activation and Sensitization: Implications for Mechanisms of Migraine Headache Onset.

Authors:  Jun Zhao; Dan Levy
Journal:  J Neurosci       Date:  2018-04-27       Impact factor: 6.167

2.  Protease activated receptor 2 (PAR2) activation causes migraine-like pain behaviors in mice.

Authors:  Shayne N Hassler; Fatima B Ahmad; Carolina C Burgos-Vega; Scott Boitano; Josef Vagner; Theodore J Price; Gregory Dussor
Journal:  Cephalalgia       Date:  2018-05-31       Impact factor: 6.292

Review 3.  Calcium channels and synaptic transmission in familial hemiplegic migraine type 1 animal models.

Authors:  Osvaldo D Uchitel; Carlota González Inchauspe; Mariano N Di Guilmi
Journal:  Biophys Rev       Date:  2013-12-03

4.  Cranial dural permeability of inflammatory nociceptive mediators: Potential implications for animal models of migraine.

Authors:  Jun Zhao; Dara Bree; Michael G Harrington; Andrew M Strassman; Dan Levy
Journal:  Cephalalgia       Date:  2016-08-19       Impact factor: 6.292

Review 5.  Modelling headache and migraine and its pharmacological manipulation.

Authors:  S E Erdener; T Dalkara
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

6.  Differential contribution of COX-1 and COX-2 derived prostanoids to cortical spreading depression-Evoked cerebral oligemia.

Authors:  Helaine Gariepy; Jun Zhao; Dan Levy
Journal:  J Cereb Blood Flow Metab       Date:  2016-07-20       Impact factor: 6.200

Review 7.  Impact of mast cells in depression disorder: inhibitory effect of IL-37 (new frontiers).

Authors:  Pio Conti; Alessandro Caraffa; Gianpaolo Ronconi; Chiara M Conti; Spiros K Kritas; Filiberto Mastrangelo; Lucia Tettamanti; Theoharis C Theoharides
Journal:  Immunol Res       Date:  2018-06       Impact factor: 2.829

8.  Sex-, stress-, and sympathetic post-ganglionic-dependent changes in identity and proportions of immune cells in the dura.

Authors:  Lisa A McIlvried; J Agustin Cruz; Lisa A Borghesi; Michael S Gold
Journal:  Cephalalgia       Date:  2016-07-11       Impact factor: 6.292

9.  Mast cell activation contributes to sickle cell pathobiology and pain in mice.

Authors:  Lucile Vincent; Derek Vang; Julia Nguyen; Mihir Gupta; Kathryn Luk; Marna E Ericson; Donald A Simone; Kalpna Gupta
Journal:  Blood       Date:  2013-06-17       Impact factor: 22.113

10.  Nucleotide homeostasis and purinergic nociceptive signaling in rat meninges in migraine-like conditions.

Authors:  Gennady G Yegutkin; Cindy Guerrero-Toro; Erkan Kilinc; Kseniya Koroleva; Yevheniia Ishchenko; Polina Abushik; Raisa Giniatullina; Dmitriy Fayuk; Rashid Giniatullin
Journal:  Purinergic Signal       Date:  2016-07-01       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.